• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于患者特异性诱导多能干细胞衍生的肝细胞样细胞的常染色体隐性遗传性高胆固醇血症模型研究。

Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells as a Model to Study Autosomal Recessive Hypercholesterolemia.

机构信息

Department of Molecular Medicine, Faculty of Advanced Biomedical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Stem Cell Institute, Department of Development and Regeneration, University of Leuven (KULeuven), Leuven, Belgium.

出版信息

Stem Cells Dev. 2021 Jul 15;30(14):714-724. doi: 10.1089/scd.2020.0199. Epub 2021 Jun 8.

DOI:10.1089/scd.2020.0199
PMID:33938231
Abstract

Autosomal recessive hypercholesterolemia (ARH) is a rare monogenic disorder caused by pathogenic variants in the low-density lipoprotein receptor (LDLR) adaptor protein 1 () gene, encoding for the LDLRAP1 protein, which impairs internalization of hepatic LDLR. There are variable responses of ARH patients to treatment and the pathophysiological mechanism(s) for this variability remains unclear. This is in part caused by absence of reliable cellular models to evaluate the effect of mutations on the LDLRAP1 protein function and its role in LDLR internalization. Here, we aimed to validate patient-specific induced pluripotent stem cell (iPSC)-derived hepatocyte-like cells (HLCs) as an appropriate tool to model ARH disease. Fibroblasts from an ARH patient carrying the recently reported nonsense mutation, c.649G>T, were reprogrammed into hiPSCs using Sendai viral vectors. In addition, we used clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) to create an gene (also known as ) knockout in two different human iPSC lines. ARH patient-derived iPSCs, ARH-knockout iPSC lines, and control iPSCs were efficiently differentiated into HLCs. Western blot analysis demonstrated the absence of LDLRAP1 in HLCs derived from patient and knockout iPSCs, and this was associated with a decreased low-density lipoprotein cholesterol (LDL-C) uptake in ARH-mutant/knockout HLCs compared to control HLCs. In conclusion, we determined that the recently described point mutation in induces absence of the LDLRAP1 protein, similar to what is seen following knockout. This causes a decreased, although not fully absent, LDL-uptake in ARH-mutant/knockout HLCs. As knockout of or presence of the point mutation results in absence of LDLRAP1 protein, residual LDL uptake might be regulated by LDLRAP1-independent internalization mechanisms. Patient-specific iPSC-derived HLCs can therefore be a powerful tool to further decipher mutations and function of the protein.

摘要

常染色体隐性高胆固醇血症 (ARH) 是一种罕见的单基因疾病,由低密度脂蛋白受体 (LDLR) 衔接蛋白 1 () 基因中的致病性变异引起,该基因编码 LDLRAP1 蛋白,可损害肝脏 LDLR 的内化。ARH 患者对治疗的反应存在差异,其病理生理机制尚不清楚。部分原因是缺乏可靠的细胞模型来评估突变对 LDLRAP1 蛋白功能的影响及其在 LDLR 内化中的作用。在这里,我们旨在验证患者特异性诱导多能干细胞 (iPSC) 衍生的肝细胞样细胞 (HLC) 作为一种合适的工具来模拟 ARH 疾病。使用 Sendai 病毒载体将来自携带最近报道的无义突变 c.649G>T 的 ARH 患者的成纤维细胞重编程为 hiPSC。此外,我们使用成簇规律间隔短回文重复 (CRISPR)/CRISPR 相关蛋白 9 (Cas9) 在两种不同的人 iPSC 系中创建 基因 (也称为 ) 敲除。ARH 患者来源的 iPSC、ARH 敲除 iPSC 系和对照 iPSC 均有效地分化为 HLC。Western blot 分析表明,源自患者和敲除 iPSC 的 HLC 中 LDLRAP1 缺失,与对照 HLC 相比,ARH 突变/敲除 HLC 中的低密度脂蛋白胆固醇 (LDL-C) 摄取减少。总之,我们确定最近描述的 中的点突变导致 LDLRAP1 蛋白缺失,类似于 敲除后观察到的情况。这导致 ARH 突变/敲除 HLC 中的 LDL 摄取减少,尽管并非完全缺失。由于 或存在点突变导致 LDLRAP1 蛋白缺失,残留的 LDL 摄取可能受到 LDLRAP1 非依赖性内化机制的调节。因此,患者特异性 iPSC 衍生的 HLC 可以成为进一步阐明 突变和蛋白功能的有力工具。

相似文献

1
Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells as a Model to Study Autosomal Recessive Hypercholesterolemia.基于患者特异性诱导多能干细胞衍生的肝细胞样细胞的常染色体隐性遗传性高胆固醇血症模型研究。
Stem Cells Dev. 2021 Jul 15;30(14):714-724. doi: 10.1089/scd.2020.0199. Epub 2021 Jun 8.
2
A new variant (c.1A>G) in LDLRAP1 causing autosomal recessive hypercholesterolemia: Characterization of the defect and response to PCSK9 inhibition.LDLRAP1 基因中的一个新变异(c.1A>G)导致常染色体隐性高胆固醇血症:缺陷特征及对 PCSK9 抑制的反应。
Atherosclerosis. 2019 May;284:223-229. doi: 10.1016/j.atherosclerosis.2019.01.010. Epub 2019 Jan 25.
3
Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia.基因校正的 iPSC 衍生的肝细胞样细胞在恢复同源性家族性高胆固醇血症中低密度脂蛋白摄取中的功能和免疫原性。
Sci Rep. 2019 Mar 18;9(1):4695. doi: 10.1038/s41598-019-41056-w.
4
Disruption of autosomal recessive hypercholesterolemia gene shows different phenotype in vitro and in vivo.常染色体隐性高胆固醇血症基因的破坏在体外和体内表现出不同的表型。
Circ Res. 2004 Oct 29;95(9):945-52. doi: 10.1161/01.RES.0000146946.78540.46. Epub 2004 Oct 7.
5
Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia.常染色体隐性高胆固醇血症小鼠中低密度脂蛋白受体的正常分选但内吞作用缺陷。
J Biol Chem. 2003 Aug 1;278(31):29024-30. doi: 10.1074/jbc.M304855200. Epub 2003 May 13.
6
Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail.常染色体隐性遗传性高胆固醇血症磷酸酪氨酸结合域与 LDL 受体尾部复合物的原子结构。
Proc Natl Acad Sci U S A. 2012 May 1;109(18):6916-21. doi: 10.1073/pnas.1114128109. Epub 2012 Apr 16.
7
The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits.模块化衔接蛋白常染色体隐性高胆固醇血症(ARH)促进低密度脂蛋白受体聚集到网格蛋白包被小窝中。
J Biol Chem. 2005 Dec 9;280(49):40996-1004. doi: 10.1074/jbc.M509394200. Epub 2005 Sep 22.
8
S-nitrosylation of ARH is required for LDL uptake by the LDL receptor.ARH 的 S-亚硝基化对于 LDL 受体摄取 LDL 是必需的。
J Lipid Res. 2013 Jun;54(6):1550-1559. doi: 10.1194/jlr.M033167. Epub 2013 Apr 7.
9
Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia.尿液样本来源的人诱导多能干细胞作为研究PCSK9介导的常染色体显性高胆固醇血症的模型。
Dis Model Mech. 2016 Jan;9(1):81-90. doi: 10.1242/dmm.022277. Epub 2015 Nov 19.
10
Adaptor protein disabled-2 modulates low density lipoprotein receptor synthesis in fibroblasts from patients with autosomal recessive hypercholesterolaemia.衔接蛋白失活-2调节常染色体隐性高胆固醇血症患者成纤维细胞中低密度脂蛋白受体的合成。
Hum Mol Genet. 2007 Nov 15;16(22):2751-9. doi: 10.1093/hmg/ddm232. Epub 2007 Aug 29.

引用本文的文献

1
Development of a method of passaging and freezing human iPS cell-derived hepatocytes to improve their functions.开发一种传代和冻存人诱导多能干细胞源性肝细胞的方法,以改善其功能。
PLoS One. 2023 May 18;18(5):e0285783. doi: 10.1371/journal.pone.0285783. eCollection 2023.
2
Circulating Human Metabolites Resulting from TOTUM-070 Absorption (a Plant-Based, Polyphenol-Rich Ingredient) Improve Lipid Metabolism in Human Hepatocytes: Lessons from an Original Ex Vivo Clinical Trial.源自 TOTUM-070 吸收(一种植物来源、富含多酚的成分)的循环人体代谢物可改善人肝细胞中的脂质代谢:来自原始离体临床试验的教训。
Nutrients. 2023 Apr 14;15(8):1903. doi: 10.3390/nu15081903.
3
Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells.
利用 iPSC 分化的肝细胞样细胞进行疾病建模和药物发现的进展。
Genes (Basel). 2022 Mar 24;13(4):573. doi: 10.3390/genes13040573.
4
Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery.人诱导多能干细胞衍生肝模型在药物发现中的现状和挑战。
Cells. 2022 Jan 27;11(3):442. doi: 10.3390/cells11030442.
5
Induction and Maturation of Hepatocyte-Like Cells : Focus on Technological Advances and Challenges.肝样细胞的诱导与成熟:聚焦技术进展与挑战
Front Cell Dev Biol. 2021 Nov 26;9:765980. doi: 10.3389/fcell.2021.765980. eCollection 2021.
6
A case of autosomal recessive hypercholesterolemia with a novel mutation in the gene.一例常染色体隐性高胆固醇血症患者,其基因存在新突变。
Clin Pediatr Endocrinol. 2021;30(4):201-204. doi: 10.1297/cpe.30.201. Epub 2021 Oct 1.